Page 25 - ESHRE2019
P. 25
Eye disease ‐ RIKEN
1 patient treated, stop vision deterioration, no adverse effects Autologous transplant
Trial stopped because mutations detected in iPS of second patient Application for allogeneic HLA matched transplants
A promising start
Before After
20
PRECONGRESS COURSE 13 I VIENNA, AUSTRIA – 23 JUNE 2019 23
